NCT01384175

Brief Summary

The aim of the present study was to assess the efficacy of thoracic epidural anesthesia followed by postoperative epidural infusion and patient-controlled epidural analgesia with ropivacaine/fentanyl in off-pump coronary artery bypass grafting

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jan 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2011

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 28, 2011

Completed
Last Updated

June 29, 2011

Status Verified

June 1, 2011

Enrollment Period

1.6 years

First QC Date

June 17, 2011

Last Update Submit

June 28, 2011

Conditions

Keywords

Epidural AnalgesiaOPCABPCEA

Outcome Measures

Primary Outcomes (1)

  • Duration of postoperative mechanical ventilation

    Duration of postoperative mechanical ventilation, hours

    Participants will be followed for the duration of mechanical ventilation, an expected average of 6 hours

Secondary Outcomes (1)

  • Hemodynamic stability

    All period of operation and during 24 hours postoperatively

Study Arms (3)

intravenous analgesia

ACTIVE COMPARATOR

Patients received postoperative analgesia by intravenous fentanyl 10 µg/ml 3-8 mL/h.

Procedure: intravenous analgesia

epiduaral infusion

ACTIVE COMPARATOR

Patients received epidural analgesia intraoperatively with ropivacaine 0.75% 1 mg/kg and fentanyl 1 µg/kg followed by continuous epidural infusion of ropivacaine 0.2% 3-8 mL/h and fentanyl 2 µg/mL postoperatively.

Procedure: epidural infusion

patient-controlled epidural analgesia

ACTIVE COMPARATOR

In addition to epidural anesthesia and epidural infusion, postoperatively patients received patient-controlled epidural analgesia with ropivacaine/fentanyl bolus 1 mL, lock-out interval 12 min.

Procedure: patient-controlled epidural analgesia

Interventions

Patients received postoperative analgesia with intravenous infusion of fentanyl 10 µg/ml 3-8 mL/h

intravenous analgesia

Postoperative analgesia was performed using continuous epidural infusion of ropivacaine 0.2% 3-8 mL/h and fentanyl 2 µg/mL

epiduaral infusion

Postoperative analgesia was performed by continuous epidural infusion of ropivacaine/fentanyl mixture combined with patient-controlled epidural analgesia with ropivacaine/fentanyl bolus 1 mL, lock-out interval 12 min.

patient-controlled epidural analgesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presence of coronary artery disease
  • ASA II-III
  • elective off-pump coronary artery bypass

You may not qualify if:

  • age \< 18 years
  • severe valve dysfunction or peripheral vascular disease
  • simultaneous interventions (carotid endarterectomy, aneurysm repair, etc.)
  • transfer to CPB during surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Anesthesiology, Northern SMU

Arkhangelsk, Russia

Location

Related Publications (1)

  • Kirov MY, Eremeev AV, Smetkin AA, Bjertnaes LJ. Epidural anesthesia and postoperative analgesia with ropivacaine and fentanyl in off-pump coronary artery bypass grafting: a randomized, controlled study. BMC Anesthesiol. 2011 Sep 18;11:17. doi: 10.1186/1471-2253-11-17.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Mikhail Y Kirov

    Northern State Medical University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 17, 2011

First Posted

June 28, 2011

Study Start

January 1, 2008

Primary Completion

August 1, 2009

Study Completion

September 1, 2009

Last Updated

June 29, 2011

Record last verified: 2011-06

Locations